What does Dr. Silke Van Genechten do?

Dr. Silke Van Genechten is a specialist medical practice in Genk. Private Limited, started on 16 January 2023, 1 establishment.

What is the address of Dr. Silke Van Genechten?

The registered office of Dr. Silke Van Genechten is located at Meistraat 12, 3600 Genk.

Is Dr. Silke Van Genechten still active?

Yes. According to the CBE (1 October 2026) Dr. Silke Van Genechten is active, legal situation “Normale toestand”, started on 16 January 2023.

Is Dr. Silke Van Genechten registered on Peppol?

Yes, Dr. Silke Van Genechten is registered on the Peppol network with ID 0208:0797194597.

What is the enterprise number of Dr. Silke Van Genechten?

The enterprise number of Dr. Silke Van Genechten is BE0797194597.

When was Dr. Silke Van Genechten founded?

Dr. Silke Van Genechten was founded on 16 January 2023.

Who are the directors of Dr. Silke Van Genechten?

According to the 2025 annual accounts, the directors of Dr. Silke Van Genechten are: Silke Van Genechten.

Is Dr. Silke Van Genechten a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 January 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Silke Van Genechten make in 2025?

Dr. Silke Van Genechten recorded a loss after taxes of € 22,990 in financial year 2025.

What is the revenue of Dr. Silke Van Genechten?

As a small company, Dr. Silke Van Genechten is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -6,450.

Dr. Silke Van Genechten (Private Limited) - Genk

Dossier Dr. Silke Van Genechten, printed on 1 October 2026 from databakkes.be/en/0797194597/dr-silke-van-genechten. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Silke Van Genechten from Genk, company number BE0797194597, closed financial year 2025 with a result of € -22,990 after tax. For that financial year Dr. Silke Van Genechten recorded a gross margin of € -6,450 and equity of € 4,314. Compared with financial year 2024, the result moved from € -2,526 to € -22,990. The company made a loss. The buffer shrank hard: equity is 84 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Shrank hard

€ 4,314

▼ 84% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -22,990

▼ 810 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 13,462

▲ 100% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 814.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 37,226

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 19,615

▼ 25% vs 2024

€ 6,862 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 2,464

▲ € 2,402 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 186

▼ 67% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 37,348 Gross margin 2023: € 37,348 First fiscal year in the series	€ 12,874 Gross margin 2024: € 12,874 ▼ 66% vs 2023 (€ 37,348) Unfavourable step	€ -6,450 Gross margin 2025: € -6,450 ▼ € 19,325 vs 2024 (€ 12,874) Unfavourable step	▼ € 19,325
Profit after taxes	€ 26,330 Profit after taxes 2023: € 26,330 First fiscal year in the series	€ -2,526 Profit after taxes 2024: € -2,526 ▼ € 28,856 vs 2023 (€ 26,330) Unfavourable step	€ -22,990 Profit after taxes 2025: € -22,990 ▼ € 20,464 vs 2024 (€ -2,526) Unfavourable step	▼ € 20,464
Equity	€ 29,830 Equity 2023: € 29,830 First fiscal year in the series	€ 27,304 Equity 2024: € 27,304 ▼ 8% vs 2023 (€ 29,830) Unfavourable step	€ 4,314 Equity 2025: € 4,314 ▼ 84% vs 2024 (€ 27,304) Unfavourable step	▼ 84%
Total debts	€ 44,552 Total debts 2023: € 44,552 First fiscal year in the series	€ 27,058 Total debts 2024: € 27,058 ▼ 39% vs 2023 (€ 44,552) Favourable step	€ 83,267 Total debts 2025: € 83,267 ▲ 208% vs 2024 (€ 27,058) Unfavourable step	▲ 208%
Cash	€ 13,955 Cash 2023: € 13,955 First fiscal year in the series	€ 6,738 Cash 2024: € 6,738 ▼ 52% vs 2023 (€ 13,955) Unfavourable step	€ 13,462 Cash 2025: € 13,462 ▲ 100% vs 2024 (€ 6,738) Favourable step	▲ 100%
Retained profit	€ 26,330 Retained profit 2023: € 26,330 First fiscal year in the series	€ 23,804 Retained profit 2024: € 23,804 ▼ 10% vs 2023 (€ 26,330) Unfavourable step	€ 814 Retained profit 2025: € 814 ▼ 97% vs 2024 (€ 23,804) Unfavourable step	▼ 97%
Bank debt	€ 32,469 Bank debt 2023: € 32,469 First fiscal year in the series	€ 26,184 Bank debt 2024: € 26,184 ▼ 19% vs 2023 (€ 32,469) Favourable step	€ 19,615 Bank debt 2025: € 19,615 ▼ 25% vs 2024 (€ 26,184) Favourable step	▼ 25%
Balance sheet total	€ 74,382 Balance sheet total 2023: € 74,382 First fiscal year in the series	€ 54,361 Balance sheet total 2024: € 54,361 ▼ 27% vs 2023 (€ 74,382) Unchanged	€ 87,581 Balance sheet total 2025: € 87,581 ▲ 61% vs 2024 (€ 54,361) Unchanged	▲ 61%

Key figures of Dr. Silke Van Genechten, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Silke Van Genechten?

What happened at Dr. Silke Van Genechten in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: loss of € 22,990. Source: NBB ↗
Jan 16, 2023 New establishment in Genk. KBO
2023 Silke Van Genechten became a director. NBB
Jan 16, 2023 Start of the company according to the CBE. KBO

In short

From € 26,330 profit in 2023 to € 22,990 loss in 2025.

Paid € 7,694 in corporate taxes since 2023.

Best year ever: 2023, with € 26,330 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Silke Van Genechten? We notify you, reason included.

Follow Dr. Silke Van Genechten

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Silke Van Genechten

Dr. Silke Van Genechten

Behind Dr. Silke Van Genechten is Silke Van Genechten.

See the full network in the app

Directors

According to the 2025 annual accounts

Silke Van Genechten

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Meistraat 12

3600 Genk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0797.194.597
VAT number: BE 0797.194.597
Registered office: Meistraat 12, 3600 Genk
Names & denominations: Dr. Silke Van Genechten
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 January 2023
Peppol: Active · Active since 1 Jan 2001
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗